- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
XtalPi Inc. Announces New Intelligent Automation Brand
The company also announced a new automation facility to be located in Shanghai.
XtalPi Inc. announced the launch of a new brand called XtalPi Intelligent Automation. The brand will focus on the development of laboratory automation platforms and will include both hardware and software solutions.
"Our unwavering dedication is to create a robust, intelligent R&D infrastructure, curate tools tailored for optimal data flow, and lead the charge in next-generation automated lab systems," Jian Ma, CEO of XtalPi, said in a press release. "Our infrastructure is meticulously designed to leverage the immense potential of big data. These data are analyzed by AI to provide insights and ideas that guide and accelerate R&D processes. Our diverse portfolio, ranging from individual automated workstations to expansive cluster automation and specialized chemical synthesis services for drug discovery, stands as a testament to our commitment to transforming how science is conducted in the future."
The company made the announcement at the inaugural Intelligent Automation Forum in Shaghai, China.
A new facility will also be built in Shanghai. It is scheduled to go live during the third quarter of 2023 and its initial work will be focused on drug discovery and other pharmaceutical projects.
How Can Pharma Companies Join the Digital Therapeutics Revolution?
August 5th 2022More and more companies are joining forces with software developers to create innovative products. But many are learning the hard way that making next-generation digital therapeutics isn’t as easy as signing a partnership agreement.
